Swiss National Bank’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.91M Buy
158,600
+3,000
+2% +$91.8K ﹤0.01% 1347
2026
Q1
$5.18M Hold
155,600
– – ﹤0.01% 1351
2025
Q4
$5.38M Buy
155,600
+2,800
+2% +$89.3K ﹤0.01% 1310
2025
Q3
$4.16M Buy
152,800
+2,000
+1% +$48.4K ﹤0.01% 1435
2025
Q2
$3.17M Hold
150,800
– – ﹤0.01% 1539
2025
Q1
$2.47M Buy
150,800
+1,200
+0.8% +$25.6K ﹤0.01% 1631
2024
Q4
$3.84M Buy
149,600
+16,500
+12% +$467K ﹤0.01% 1486
2024
Q3
$4.22M Buy
133,100
+8,400
+7% +$319K ﹤0.01% 1434
2024
Q2
$4.38M Buy
124,700
+13,300
+12% +$527K ﹤0.01% 1349
2024
Q1
$4.89M Buy
111,400
+26,300
+31% +$1.13M ﹤0.01% 1313
2023
Q4
$3.03M Sell
85,100
-21,900
-20% -$654K ﹤0.01% 1610
2023
Q3
$2.89M Buy
107,000
+3,700
+4% +$93.8K ﹤0.01% 1611
2023
Q2
$2.43M Buy
103,300
+20,300
+24% +$417K ﹤0.01% 1762
2023
Q1
$1.14M Sell
83,000
-9,800
-11% -$163K ﹤0.01% 2180
2022
Q4
$1.69M Buy
92,800
+2,100
+2% +$35.3K ﹤0.01% 2007
2022
Q3
$1.35M Buy
90,700
+26,900
+42% +$349K ﹤0.01% 2147
2022
Q2
$880K Hold
63,800
– – ﹤0.01% 2439
2022
Q1
$714K Buy
63,800
+4,600
+8% +$67.8K ﹤0.01% 2518
2021
Q4
$1.4M Buy
+59,200
New +$1.38M ﹤0.01% 2278

Other funds holding IDYA

Swiss National Bank's IDYA Position: Q2 2026 in Review

Swiss National Bank increased its IDEAYA Biosciences (IDYA) stake by 1.9% in Q2 2026, buying an estimated $91.8K and bringing the position to 158,600 shares worth $5.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1347.

Swiss National Bank first reported a position in IDYA in Q4 2021 and has held it in 19 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Swiss National Bank held 158,600 shares of IDEAYA Biosciences worth $5.91M as of Q2 2026.
  • Swiss National Bank bought 3,000 IDEAYA Biosciences shares in Q2 2026, an estimated $91.8K.
  • IDEAYA Biosciences made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1347 holding.
  • Swiss National Bank first reported a position in IDEAYA Biosciences in Q4 2021 and has held it in 19 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.